Reference materials on peptide documentation, testing standards, and publicly reported safety data — compiled for patient education.
COA reading checklists, pharmacy vetting guides and plain-English peptide chemistry. No more than a few emails a month.
A side-by-side comparison of grey-market, research-market, and GMP/pharmacy-release documentation — what's tested at each tier, and why purity alone isn't a safety profile.
Read the comparison →A compiled reference of publicly available government health alerts, regulatory data, and peer-reviewed case reports on unregulated peptide products, across five jurisdictions.
View the reference PDF →Every product in the AJ Peptide lineup with a plain-English description, the clinical trials behind it, and the six-peptide pipeline we're holding for FDA rulemaking. Each vial from a named 503A pharmacy with a Certificate of Analysis you can read.
View the catalog →Semaglutide and tirzepatide results across the heart, kidneys, liver, lungs and joints — twelve NEJM and Heart trials, what they found, and what that does and doesn't mean for healthy aging.
Read the evidence →